Introduction
The transmembrane receptor Notch1 plays a key role in embryonal development, cellular dierentiation and tumour development. Biochemical and genetic analysis of Notch signalling has established that the intracellular domain of Notch (Notch-IC) is the eector module which transfers the signal (Kopan et al., 1996; Schroeter et al., 1998; Jarriault et al., 1995 Jarriault et al., , 1998 Artavanis-Tsakonas et al., 1999) .
The Notch-IC module is characterized by three domains, which have been conserved throughout evolution: (i) the RAM domain adjacent to the transmembrane domain is the major docking site for the RBP-J protein (Jarriault et al., 1995; Tamura et al., 1995; Aster et al., 1997) ; (ii) the ankyrin repeat domain (ANK) adjacent to the RAM domain mediates further protein-protein interactions (Artavanis-Tsakonas et al., 1999) ; (iii) the C-terminal domain carries two characteristic features: a polyglutamine region (OPA) and a proline, glutamic acid, serine and threonine rich region termed PEST. Recently, intrinsic transcriptional activation capacity has been assigned to the Notch-IC fragment carrying the OPA motif (Kurooka et al., 1998) .
The phenotype of mutant mice lacking either RBP-J or Notch1 is almost identical, indicating that RBP-J might be the major downstream target of Notch signalling in development (Swiatek et al., 1994; Conlon et al., 1995; Oka et al., 1995; de la Pompa et al., 1997) . RBP-J represses transcription by binding to speci®c sequence motifs in the promoter of genes and recruits corepressors like SMRT or CIR (Dou et al., 1994; Kao et al., 1998; Hsieh et al., 1999) . The Notch-IC/RBP-J interaction abolishes the repressor function of RBP-J and activates transcription. RBP-J response elements have been described in the promoter region of the mammalian HES-1 and HES-5 genes, which encode for mammalian helix ± loop ± helix factors structurally related to the Drosophila hairy and Enhancer of split proteins (Jarriault et al., 1995; Nishimura, 1998) .
Constitutive activation of the Notch receptor has been linked to oncogenesis and cell fate decision in T cells (Ellisen et al., 1991; Pear et al., 1996; Robey et al., 1996; Washburn et al., 1997; von Boehmer, 1997 ). More recently it was shown that Notch-IC can confer anchorage independent growth to E1A immortalized baby rat kidney cells, linking again activated Notch to cellular transformation (Capobianco et al., 1997) .
We have de®ned the transactivation domain of Notch-IC and generated Notch-IC mutants which do not bind to RBP-J and/or lack a transactivation domain. A Notch-IC mutant consisting of the ANK domain cannot activate RBP-J signalling but can still cooperate with E1A in mediating anchorage independent growth. Thus, RBP-J dependent transcriptional activation by Notch-IC is not required for neoplastic transformation.
Results
The transferable transactivation domain of Notch-IC resides in the C-terminal part of the molecule and includes OPA and PEST motifs
In order to identify the transferable transactivation domain of Notch-IC, we fused N-or C-terminal deletion mutants to the yeast GAL4 DNA binding domain and tested these GAL4 chimeras in two cell lines of diverse origin: the SV 40 transformed monkey kidney cell line COS-1 and the Burkitt's lymphoma cell line HH514.
C-terminal truncation of the Notch-IC fragment, which deleted the OPA and PEST motifs, abolished the transactivating potential of Notch-IC ( Figure 1a , rows 2 ± 4). The isolated OPAPEST fragment showed strong transactivating potential in both cell lines. The isolated OPA containing fragment was signi®cantly less active than OPAPEST, indicating that they both contribute to the transcription activation domain (TAD) of Notch-IC (Figure 1a , rows 11 ± 14). Variations in protein expression levels did not account for the diverse transactivation activities of the Notch fragments ( Figure 1b) . All GAL4/Notch-IC alleles were tested for transactivation of a control reporter construct, lacking the GAL4 binding motif. As expected none of the Notch-IC alleles activated this control promoter (data not shown). In order to con®rm our results we tested transcriptional activation of the GAL1 promoter in yeast. While the GAL4-OPAPEST chimeric fragment exhibited strong transactivation activity in the context of this promoter, the GAL4-OPA fusion was inactive (data not shown). This result was consistent with the observation that glutamine-rich TADs of mammalian transcription factors do not activate the yeast GAL1 promoter (KuÈ nzler et al., 1994) .
Neither isolated RAM nor ANK or the RAMANK fragment can transactivate the GAL4 responsive reporter gene ( Figure 1a , rows 5, 7 and 10). N-terminal truncations of the Notch-IC fragment deleting RAM and ANK motifs ( Figure 1a , ICDRAM and Cterm, rows 8 and 11) further enhanced the activity of the proteins, indicating that RAM and ANK domains do not transactivate in the context of the GAL4 driven promoter.
Activation of RBP-J dependent promoters by Notch-IC: role of the TAD and the RAMANK domain HES-1 and HES-5 are well characterized target genes of Notch-IC (Takebayashi et al., 1994 (Takebayashi et al., , 1995 Nishimura et al., 1998) . The promoters of both genes carry RBP-J recognition sites and are activated by Notch-IC signi®cantly, although to dierent degrees. Compared to the HES-1 promoter, the HES-5 promoter was ten times more sensitive to Notch-IC transactivation ( Figure 2a ). C-terminal deletion derivatives lacking the transferable TAD of Notch-IC showed reduced but, unexpectedly, still signi®cant activation of both promoters.
In order to exclude potential further cis-acting elements within these cellular promoters, we tested an arti®cial promoter construct, carrying multimerized RBP-J recognition sites upstream of a minimal bglobin promoter (Kurooka et al., 1998) . Activation of this RBP-J dependent reporter construct was tested by cotransfection of Notch-IC derivatives in three cell lines of dierent origin, COS-1, HH514 and HeLa cells ( Figure 2b , lane 2). Expression levels of the various Figure 1 The TAD of Notch-IC consists of OPA and PEST motif containing domains. (a) COS-1 and HH514 cells were cotransfected with expression constructs for the Notch-IC alleles and GAL4-luciferase reporter genes. Activation of the reporter constructs is expressed as fold activation compared to control vector transfection. Error bars represent the standard deviation of at least three independent experiments. (b) Expression of the Notch-IC alleles in COS-1 was analysed by Western blot detection of either an internal MYC-tag (lanes 1 ± 6) or the GAL4 DNA binding domain (lanes 7 ± 13) Notch-IC derivatives after transfection did not account for their diverse biological activity. This reduction was seen most pronounced in the COS-1 cell line when compared to the results obtained in HH514 or HeLa and con®rmed that the transactivation domain of Notch-IC resides in the C-terminus of the protein. Transactivation in HH514 cells was less dependent on the PEST motif than in COS-1 and HeLa cells, indicating that the relative contribution of both motifs to the transactivation capacity of the Notch-IC fragments might be in¯uenced by the cellular background.
However, the RAMANK construct could still signi®cantly activate RBP-J dependent transcription in all cell lines tested. This indicated that the activity of the Notch-IC derivatives was not abolished by deletion of the entire C-terminal TAD domain.
Transactivation of the RBP-J dependent promoter was always dependent on the RAM domain within the Notch-IC protein, since N-terminal truncation deleting . If this relief of repression would exclusively account for the activity of the RAMANK domain lacking the TAD, the relative activity of the RBP-J reporter gene in the presence of the RAMANK fragment should not exceed the activity of an equivalent reporter gene lacking the RBP-J binding sites. In our experiment both promoter constructs show very low basal activity and activation of the RBP-J promoter by Notch-IC results in signi®cant activation compared to the control plasmid (Figure 3) . We conclude that we measured transactivation and not derepression in our system.
E1A and the Notch-IC ANK domain cooperate in neoplastic transformation
It has been shown recently that Notch1-IC can cooperate with the Adenovirus early antigen 1A (E1A) in neoplastic transformation. We repeated these experiments in order to determine whether neoplastic transformation can be assigned to a speci®c Notch-IC domain. Speci®cally we wanted to investigate whether the transferable transactivation domain (OPA and PEST) or the RBP-J interaction domain (RAM) were required for E1A cotransformation. RK3E (ATTC) are baby rat kidney cells immortalized by E1A. Since we found that Notch-IC expression was heterogeneous and unstable in long term RK3E transfectants, we performed short term assays for anchorage independent growth. RK3E cells were transiently transfected with the series of expression constructs encoding dierent Notch-IC alleles and tested for anchorage independent growth in semisolid media. Two weeks after transfection and plating, those colonies were counted which had reached the same size as colonies transformed by activated Ras v12 ( Figure 4a and Table  1 ). The minimal Notch-IC derivative which was able to promote anchorage independent growth was the ANK domain fragment. Deletion of this fragment resulted in complete loss of activity, while deletion of the RAM domain or the TAD did not impair neoplastic transformation. This biological activity of the ANK domain was speci®c for Notch-IC since other ankyrin repeat containing proteins like IkappaB could not substitute for Notch-IC in this assay (data not shown). All results were con®rmed by testing MTE1A cells, which express E1A under the control of the metal- Transformation by Notch is independent of RBP-J signalling E Dumont et al lothionin promoter (Zerler et al., 1986) . In order to exclude speci®c contributions of the cellular background of the RK3E cells, the Notch-IC, the RAMANK and the ANK fragments were tested for RBP-J dependent transcription in these cells ( Figure  4b ). The ANK fragment did not show any activity in these reporter assays. These results suggest that (i) the transactivation domain is not required for neoplastic transformation and (ii) triggering of the RBP-J pathway is not an essential mechanism of E1A/Notch cotransformation.
Discussion
In summary our results show that Notch-IC mediates RBP-J dependent transactivation by two dierent mechanisms. The ®rst mechanism requires a transferable transactivation domain which combines the characteristic features of two classical TADs: a glutamine-rich region and a proline-, serine-and threonine-rich region. The cooperation of both is required for optimal promoter activation.
The second mechanism, accounting for approximately one third of the transactivating potential of Notch-IC, involves the concerted action of RAM and ANK domains within an RBP-J protein complex. The RAMANK domain can activate RBP-J dependent transcription although it does not carry a classical transferable transactivation domain, which was operationally de®ned in the GAL4 transcriptional activation assay. The transactivation we measure in the context of the RBP-J dependent promoter cannot be explained by neutralization of the RBP-J repressor activity. Our results indicate that the interaction of RAMANK and RBP-J triggers a gain of function event in the Notch-IC/RBP-J complex that results in active transcription by a novel mechanism.
An autonomous function for the ANK domain independent of RBP-J signalling has been described before in C. elegans and in mouse muscle cell dierentiation (Roehl et al., 1993; Shawber et al., 1996; Nofziger et al., 1999) . Here we report that the isolated ANK domain can cooperate with E1A in neoplastic transformation. The ANK domain cannot trigger RBP-J signalling, thus supports an autonomous and RBP-J independent biological activity. The viral oncoprotein EBNA2 plays a key role in transformation of primary B cells by Epstein-Barr virus. Like Notch, EBNA2 is an activator of transcription. Potential RBP-J binding motifs have been de®ned in EBNA2 responsive promoters, indicating that, like Notch-IC, EBNA2 interacts with RBP-J to exert its function. Transformation of primary B-cells by EBV, however, strictly depends on EBNA2 alleles which interact with RBP-J and encode a transactivation domain (Kie, 1996) . Thus, transformation by Notch-IC and EBNA2 most likely involves dissimilar signals.
Recently, it has been suggested that Notch might trigger anti-apoptotic signals (Deftos et al., 1998; Jehn et al., 1999) . At present we do not know the signal elicited by the Notch protein which cooperates with E1A. Anti-apoptotic pathways are known to cooperate with E1A in the transformation of baby rat kidney cells and are attractive candidates as potential downstream signals of the ANK domain.
Materials and methods

Plasmids
All mouse Notch1-IC alleles were subcloned into pcDNA3 (Invitrogen) or into pHACS1, a derivative of pcDNA3 with a N-terminal Hemagglutinin-tag (HA). Details on the construction of the expression plasmids are available on request. The luciferase reporter plasmids RBP-J(6x)-Luc (ERE-TP1-Luc/ Ga981-6) and RBP-J(0x)-Luc (Ga50-1) have been described previously (Minoguchi et al., 1997) . The GAL4 responsive promoter construct (pCR276-3) was constructed by replacing the EBNA2 responsive region of the TP-1 promoter between 7258 and 7142 relative to the TP-1 RNA start site by ®ve GAL4 binding sites. The control plasmid (pCR276-2) contains irrelevant tetracyclin repressor binding sites instead of the GAL4 binding motif.
Cell culture
The RK3E cells are rat kidney cells immortalized by the E1A oncogene (ATTC). HH514 is a single cell clone of the Burkitt's lymphoma cell line P3HR1 (Rabson et al., 1982) . COS-1, HeLa and RK3E cell lines were propagated in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% foetal bovine serum, 100 U/ml penicillin, 100 mg/ ml streptomycin and 2 mM glutamine. HH514 cells were grown in RPMI 1640 under the same conditions.
Transient transfections
COS-1 and HeLa cells were plated in 10 cm dishes and cotransfected with mouse Notch1-IC expression constructs (25 mg) and GAL4-or RBP-J-responsive luciferase reporter genes (5 mg) by calcium phosphate precipitation. HH514 cells were electroporated, using 5 mg Notch expression constructs and 5 mg reporter plasmid. RK3E cells were plated in 3.5 cm dishes and transfected with 2 mg Notch expression constructs by the Lipofectamine technique (Gibco).
Luciferase assays
All cells were harvested 36 h after transfection and luciferase activities were measured with a MicroLumat (LB96P, Berthold). Relative activation of the reporter constructs was calculated as fold activation compared to empty vector transfection and normalized for the activity of a CMVLacZ reporter gene.
Transformation assays
Thirty-six hours after transfection of 10 6 cells were seeded into 2.5 ml medium containing 0.33% Bacto-Agar (Difco) and overlaid onto a base of 2.5 ml medium containing 0.66% Agar. Colonies were counted 2 weeks after plating. Transformation by Notch is independent of RBP-J signalling E Dumont et al
Western blot analysis
Cells were harvested 36 h after transfection and resuspended in ELB lysis buer (50 mM HEPES, pH 7; 250 mM NaCl; 1% NP40; 5 mM EDTA). The extracts were subjected to SDS ± PAGE and transferred onto a PVDF membrane (Millipore). Protein expression was analysed by detection of either the HA-tag (rat monoclonal antibody 3F10, Boehringer), an internal MYC-tag (mouse monoclonal antibody 9E10) or the GAL4-DNA binding domain (mouse monoclonal antibody, Clontech). Immunoreactive proteins were detected by peroxidase-coupled secondary antibodies and enhanced chemiluminescence (Amersham).
